ArticleQuantitative imaging in medicine and surgery2024
Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ex-vivo right posterior sectionectomy for large-for-size mismatch in pediatric liver transplant recipients.Langenbeck's archives of surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Large-for-size syndrome (LFSS) is an uncommon but potentially lethal complication following adult liver transplantation (LT). Reduced-size liver transplantation (RSLT) is considered a valuable alternative to delayed fascial closure or mesh closure for preventing LFSS. In this article, we report a successful adult-to-adult RSLT case with Case Description: A short and slim, 69-year-old woman was admitted to Daping Hospital in January, 2023. The patient had previously been diagnosed with hepatitis B virus (HBV)-related hepatocellular carcinoma and acute-on-chronic liver failure. She had received 1 month of hepatoprotective and anti-HBV treatment before being admitted to Daping Hospital, and she had not suffered from any episodes of encephalopathy or upper gastrointestinal bleeding. The physical examination revealed moderate yellow staining of the skin and sclera, abdominal distension, shifting dullness, and pitting edema of the lower limbs. The laboratory test results revealed high serum total bilirubin (TBil) (121.2 µmol/L) and a long prothrombin time (PT) (23.4 s). Computed tomography (CT) showed a 3.4 cm × 2.9 cm nodule in segment V of the liver without macrovascular invasion. Due to the patient's poor liver function, conventional anti-tumor therapies (e.g., surgical resection, transcatheter arterial chemoembolization, and radiofrequency ablation) could not be used, and LT was the only feasible treatment for the patient. The graft volume (GV) of the allocated liver was measured by computed tomography volumetry (CTV). The estimated graft-recipient weight ratio (GRWR) was 3.8%, and the estimated graft weight/right anteroposterior ratio (GW/RAP) was 120.2, which indicated that the donor liver size was severely mismatched with the recipient's abdominal cavity. After meticulous surgical planning using a 3D simulation implanting model, an Conclusions: In situ right posterior graft sectionectomy is a feasible and effective strategy for preventing LFSS, especially if there is a size discrepancy between the donor liver anteroposterior dimensions and the recipient's lower right hemithorax. Accurate preoperative surgical planning is the key element in the success of the proposed size-reduction strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.